View more in
Cancer

Dr. Smith on the Results of the ECOG-ACRIN E1411 Trial in MCL

onclive.com
 2021-06-09

Mitchell R. Smith, MD, PhD, discusses the results of the phase 2 ECOG-ACRIN E1411 trial in mantle cell lymphoma. Mitchell R. Smith, MD, PhD, associate cancer center director for clinical investigations, chief, Division of Oncology and Blood Disorders, GW Cancer Center, clinical professor of medicine, GW School of Medicine and Health Sciences, discusses the results of the phase 2 ECOG-ACRIN E1411 trial (NCT01415752) in mantle cell lymphoma (MCL).

www.onclive.com

Comments / 0

Comments / 0